Jenny Hsieh | |
---|---|
Alma mater | Johns Hopkins University (PhD) |
Scientific career | |
Fields | Cell biology |
Institutions | University of Texas at San Antonio |
Website | Hsieh Lab |
Jenny Hsieh is an American cell biologist and Semmes Foundation professor at the University of Texas at San Antonio (UTSA). Her work focuses on epilepsy and stem cell biology. [1]
Hsieh received her PhD from Johns Hopkins University, where she worked with Andrew Fire. [2] In 2005, Hsieh completed a postdoctoral fellowship with Fred Gage at the Salk Institute. [3]
Hsieh was a professor at the University of Texas Southwestern Medical Center from 2006 to 2018, when she moved to the University of Texas at San Antonio (UTSA). [4] At UTSA, Hsieh holds the Semmes Foundation Chair in Cell Biology, and is the founding director of the UTSA Brain Health Consortium, a program to connect brain researchers across disciplines. [5] [6]
Hsieh's research focuses on the use of Induced pluripotent stem cells to create in vitro models of neurogenesis. She intends to use this to develop regenerative treatments for neurological disorders. [2]
During the COVID-19 pandemic, Hsieh studied the potential for neural infection by SARS-CoV-2 using neural organoids. [7] Her initial results, based on exposing neural organoids to the virus, suggested that infection of glia might be involved in neurological symptoms such as loss of taste or smell. [8]
Viral meningitis, also known as aseptic meningitis, is a type of meningitis due to a viral infection. It results in inflammation of the meninges. Symptoms commonly include headache, fever, sensitivity to light and neck stiffness.
The University of Texas at San Antonio (UTSA) is a public research university in San Antonio, Texas. With over 34,000 students, it is the largest university in San Antonio and the eighth-largest in the state of Texas. It includes four campuses across the San Antonio metropolitan area that span 725 acres of land. UTSA offers 67 bachelor's, 69 master's, and 24 doctoral degree programs. It is classified among "R2: Doctoral Universities – High research activity".
Organogenesis is the phase of embryonic development that starts at the end of gastrulation and continues until birth. During organogenesis, the three germ layers formed from gastrulation form the internal organs of the organism.
Fred "Rusty" Gage is the President of the Salk Institute for Biological Studies and the Adler Professor in the Laboratory of Genetics at the Salk Institute, and has concentrated on the adult central nervous system and the unexpected plasticity and adaptability that remains throughout the life of all mammals. His work may lead to methods of replacing brain tissue lost to stroke or Alzheimer's disease and repairing spinal cords damaged by trauma. He was the President-elect of the ISSCR in 2012.
Viral encephalitis is inflammation of the brain parenchyma, called encephalitis, by a virus. The different forms of viral encephalitis are called viral encephalitides. It is the most common type of encephalitis and often occurs with viral meningitis. Encephalitic viruses first cause infection and replicate outside of the central nervous system (CNS), most reaching the CNS through the circulatory system and a minority from nerve endings toward the CNS. Once in the brain, the virus and the host's inflammatory response disrupt neural function, leading to illness and complications, many of which frequently are neurological in nature, such as impaired motor skills and altered behavior.
HIV-associated neurocognitive disorders (HAND) are neurological disorders associated with HIV infection and AIDS. It is a syndrome of progressive deterioration of memory, cognition, behavior, and motor function in HIV-infected individuals during the late stages of the disease, when immunodeficiency is severe. HAND may include neurological disorders of various severity. HIV-associated neurocognitive disorders are associated with a metabolic encephalopathy induced by HIV infection and fueled by immune activation of macrophages and microglia. These cells are actively infected with HIV and secrete neurotoxins of both host and viral origin. The essential features of HIV-associated dementia (HAD) are disabling cognitive impairment accompanied by motor dysfunction, speech problems and behavioral change. Cognitive impairment is characterised by mental slowness, trouble with memory and poor concentration. Motor symptoms include a loss of fine motor control leading to clumsiness, poor balance and tremors. Behavioral changes may include apathy, lethargy and diminished emotional responses and spontaneity. Histopathologically, it is identified by the infiltration of monocytes and macrophages into the central nervous system (CNS), gliosis, pallor of myelin sheaths, abnormalities of dendritic processes and neuronal loss.
George Perry is the former Dean of the College of Sciences, Semmes Distinguished University Chair in Neurobiology, Professor of Biology and Chemistry at the University of Texas at San Antonio. Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.
Central nervous system diseases, also known as central nervous system disorders, are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS).
The principles that govern the evolution of brain structure are not well understood. Brain to body size scales allometrically. Small bodied mammals have relatively large brains compared to their bodies whereas large mammals have smaller brain to body ratios. If brain weight is plotted against body weight for primates, the regression line of the sample points can indicate the brain power of a primate species. Lemurs for example fall below this line which means that for a primate of equivalent size, we would expect a larger brain size. Humans lie well above the line indicating that humans are more encephalized than lemurs. In fact, humans are more encephalized than all other primates.
Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.
Viral neuronal tracing is the use of a virus to trace neural pathways, providing a self-replicating tracer. Viruses have the advantage of self replication over molecular tracers, but can also spread too quickly and cause degradation of neural tissue. Viruses which can infect the nervous system, called neurotropic viruses, spread through spatially close assemblies of neurons through synapses, allowing for their use in studying functionally connected neural networks. The use of viruses to label functionally connected neurons stems from work done by Albert Sabin who developed a bioassay which could assess the infection of viruses across neurons. Subsequent research allowed for incorporation of immunohistochemical techniques to systematically label neuronal connections. To date, viruses have been used to study multiple circuits in the nervous system.
A cerebral organoid, or brain organoid, describes an artificially grown, in vitro, miniature organ resembling the brain. Cerebral organoids are created by culturing pluripotent stem cells in a three-dimensional rotational bioreactor, and they develop over a course of months. The brain is an extremely complex system of heterogeneous tissues and consists of a diverse array of neurons. This complexity has made studying the brain and understanding how it works a difficult task in neuroscience, especially when it comes to neurodegenerative diseases. The purpose of creating an in vitro neurological model is to study these diseases in a more simple and variable space. This 3D model is free of many potential in vivo limitations. The varying physiology between human and other mammalian models limits the scope of study in neurological disorders. Cerebral organoids are synthesized tissues that contain several types of nerve cells and have anatomical features that recapitulate regions of the cortex observed in brains. Cerebral organoids are most similar to layers of neurons called the cortex and choroid plexus. In some cases, structures similar to the retina, meninges and hippocampus can form. Stem cells have the potential to grow into many different types of tissues, and their fate is dependent on many factors. Below is an image showing some of the chemical factors that can lead stem cells to differentiate into various neural tissues; a more in-depth table of generating specific organoid identity has been published since. Similar techniques are used on stem cells used to grow cerebral organoids.
Tom Solomon FRCP is Professor of Neurology, Director of the Institute of Infection and Global Health at the University of Liverpool, and Director of the National Institute for Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections. In 2021 he was elected Fellow of the UK Academy of Medical Sciences.
Igor Koralnik is an American physician, neurologist and scientist. He is one of the first physicians to study the neurologic complications caused by the human immunodeficiency virus (HIV) and is a leading researcher in the investigation of the polyomavirus JC, which causes progressive multifocal leukoencephalopathy (PML), a disease of the central nervous system that occurs in immunosuppressed individuals.
Sergiu P. Pașca is a Romanian-American scientist and physician at Stanford University in California. Pașca is a faculty member in the Department of Psychiatry and Behavioral Sciences at Stanford University, a neuroscientist and stem cell biologist and currently a NYSCF Robertson Investigator. He is part of the Stanford Neurosciences Institute, Stanford Bio-X and a fellow of the ChEM-H Institute at Stanford. Pașca was listed among New York Times Visionaries in Medicine and Sciences, and he is the recipient of the 2018 Vilcek Award for Creative Biomedical Promise from the Vlicek Foundation.
Jürgen Knoblich is a German molecular biologist. Since 2018, he is Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Symptoms of COVID-19 are variable, ranging from mild symptoms to severe illness. Common symptoms include headache, loss of smell and taste, nasal congestion and runny nose, cough, muscle pain, sore throat, fever, diarrhea, and breathing difficulties. People with the same infection may have different symptoms, and their symptoms may change over time. Three common clusters of symptoms have been identified: one respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. In people without prior ear, nose, and throat disorders, loss of taste combined with loss of smell is associated with COVID-19.
Sonia Gandhi is a British physician and neuroscientist who leads the Francis Crick Institute neurodegeneration laboratory. She holds a joint position at the UCL Queen Square Institute of Neurology. Her research investigates the molecular mechanisms that give rise to Parkinson's disease. During the COVID-19 pandemic, Gandhi was involved with the epidemiological investigations and testing efforts at the Francis Crick Institute.
Amanda Brown is an American immunologist and microbiologist as well as an associate professor of neurology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland. Brown is notable for cloning one of the first recombinant HIV viruses and developing a novel method to visualize HIV infected cells using GFP fluorescence.
While acute symptoms of COVID-19 act on the lungs, there is increasing evidence suggests that COVID-19 causes both acute and chronic neurologicalor psychological symptoms. Caregivers of COVID-19 patients also show a higher than average prevalence of mental health concerns. These symptoms result from multiple different factors.